ADH5, which facilitates the detoxification of formaldehyde, indirectly affects the pharmacokinetics and toxicity profiles of drugs like cyclophosphamide and ifosfamide, which release formaldehyde as a metabolite. Variations in ADH5 activity can alter how these drugs are metabolized in the body, impacting their efficacy and safety.